Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer

Invasion and Metastasis

Volumn 18, Issue 3, 1999, Pages 134-141

  Suzuki, Makoto ^a   Iizasa, Toshihiko ^a   Fujisawa, Takehiko ^a   Baba, Masayuki ^a   Yamaguchi, Yutaka ^a   Kimura, Hideki ^b   Suzuki, Hiroto ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA CANCER CENTER   (Japan)

Author keywords

Lung cancer; Matrix metalloproteinase; Tissue inhibitor of metalloproteinase

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; MONOCLONAL ANTIBODY; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; FIBROBLASTS; HUMANS; K562 CELLS; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; STROMAL CELLS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED;

EID: 0344199400     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024506     Document Type: Article

References (32)

1. Patterson PH: On the role of proteases, their inhibitors and the extracellullar matrix in promoting neurite outgrowth. J Physiol (Paris) 1985;80:207-211.
2. Docherty AJP, O'Connell J, Crabbe T, Angal F, Murphy G: The matrix metalloproteinases and their natural inhibitors: Prospects for treating degenerative tissue diseases. Tibtech 1992;10:200-207.
3. Woessner JF, Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-2154.
4. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284:67-68.
5. Apdaca G, Rutka JT, Bouhana K, Berens ME, Giblin JR, Rosenblum ML, McKerrow JH, Banda MJ: Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 1990;50:2322-2329.
6. Tryggvason K, Höyhtyä M, Pyke C: Type IV collagenases in invasive tumors. Breast Cancer Res Treat 1993;24:209-218.
7. Gallegos NC, Smales C, Savage FJ, Hembry RM, Boulos PB: The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer. Surg Oncol 1995;4:111-119.
8. Iwata H, Kobayashi S, Iwase H, Masaoka A, Fujimoto N, Okada Y: Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Jpn J Cancer Res 1996;87: 602-611.
9. r 92,000 gelatinase secreted by normal and malignant human cells: Isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res 1990;50: 6162-6170.
10. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991; 64:327-336.
11. Klein-Szanto AJP, Iizasa T, Momiki S, Garcia-Palazzo I, Caamano J, Metcalf R, Welsh J, Harris CC: A tobacco-specific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xeno transplanted human bronchial epithelial cells. Proc Natl Acad Sci USA 1992;89:6693-6697.
12. Brown PD, Bloxidge RE, Stuart NSA, Gatter KC, Carmichael J: Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 1993; 85:574-578.
13. Iizasa T, Momiki S, Bauer B, Caamano J, Metcalf R, Lechner J, Harris CC, Klein-Szanto AJP: Invasive tumors derived from xenotransplanted, immortalized human cells after in vivo exposure to chemical carcinogens. Carcinogenesis 1993; 14:1789-1794.
14. Kawahara E, Okada Y, Nakanishi I, Iwata K, Kojima S, Kumagai S, Yamamoto E: The expression of invasive behavior of differentiated squamous carcinoma cell line evaluated by an in vitro invasion model. Jpn J Cancer Res 1993;84:409-418.
15. Brown PD, Bloxidge RE, Anderson E, Howell A: Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis 1993;11:183-189.
16. Urbanski SJ, Edwards DR, Maitland A, Leco KJ, Watson A, Kossakowska AE: Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer 1992;66:1188-1194.
17. Tolnay E, Wiethege T, Kuhnen C, Wulf M, Voss B, Muller KM: Expression of type IV collagenase correlates with the expression of vascular endothelial growth factor in primary non-small cell lung cancer. J Cancer Res Clin Oncol 1997;123: 652-658.
18. Clarke MR, Landreneau RJ, Finkelstein SD, We TT, Ohori P, Yousem SA: Extracellular matrix expression in metastasizing and nonmetastasizing adenocarcinomas of the lung. Hum Pathol 1997;28:54-59.
19. American Joint Committee on Cancer: Manual for staging of cancer, ed 4. Philadelphia, Lippincott 1992, pp 115-122.
20. The Japan Lung Cancer Society: The General Rules for Clinical and Pathological Record of Lung Cancer. Tokyo, Kanehara Press, 1995, pp 89-121.
21. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980;102:196-202.
22. Yamachika T, Nakanishi H, Inada K, Tsukamoto T, Kato T, Fukushima M, Inoue M, Tatematsu M: A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance. Cancer 1998;82:70-77.
23. Kawano N, Osawa H, Ito T, Nagashima Y, Hirahara F, Inayama Y, Nakatani Y, Kimura S, Kitajima H, Koshikawa N, Miyazaki K, Kitamura H: Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: An immunohistochemical study. Hum Pathol 1997; 28:613-622.
24. Bissell DM, Friedman SL, Maher JJ, Roll FJ: Connective tissue biology and hepatic fibrosis: Report of a conference. Hepatology 1990;11: 488-498.
25. Nakajima M, Welch DR, Belloni PN, Nicolson GL: Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 1987;47:4869-4876.
26. Yamagata S, Ito Y, Tanaka R, Tanaka R, Shimizu S: Gelatinases of metastatic cell lines of murine colonie carcinoma as detected by substrategel electrophoresis. Biochem Biophys Res Commun 1988;151:158-162.
27. Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J, Seiki M: Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992;7:77-83.
28. Momiki S, Baba M, Caamano J, Iizasa T, Nakajima M, Yamaguchi Y, Klein-Szanto A: In vivo and in vitro invasiveness of human lung carcinoma cell lines. Invasion Metastasis 1991;11:66-75.
29. Zucker S, Lysik RM, Malik M, Bauer BA, Caamano J, Klein-Szanto A: Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines; not an invariant correlation with metastasis. Int J Cancer 1992;52:366-371.
30. Gonzalez-Avila G, Iturria C, Vadillo F, Teran L, Selman M, Perez-Tamayo R: 72-kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells. Pathobiology 1998;66:5-16.
31. Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJR: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985;318:66-69.
32. Stetler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase (TIMP-2). J Biol Chem 1989;264:17374-17378.